1-8 of 8
Muzaffar Qazilbash, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development of Donor Cell Derived Leukemia After Allogeneic Stem Cell Transplant

Sairah Ahmed, MD, Antonio Di Stasi, MD, Elizabeth J. Shpall, M.D., Issa F. Khouri, MD, Amin M. Alousi, M.D., Stefan O. Ciurea, MD, Qaiser Bashir, MD, Muzaffar Qazilbash, M.D., Roy B. Jones, MD, PhD, Yago Nieto, MD, PhD, Simrit Parmar, MD, Partow Kebriaei, MD, Nina Shah, MD, Katy Rezvani, MD, PhD, Chitra M Hosing, MD, Betul Oran, MD, Michael Andreeff, MD, PhD, Paolo Anderlini, MD, Borje S Andersson, MD, PhD, Richard E Champlin, MD, Uday Popat, MD
Journal: Blood
Blood (2013) 122 (21): 2083.
https://doi.org/10.1182/blood.V122.21.2083.2083
Published: 2013
Journal Articles

Plasmablastic Lymphoma: 28 Patient Single Institution Experience

Krina Patel, MD, Lei Feng, M.S., Yasuhiro Oki, MD, Muzaffar Qazilbash, M.D., Tariq Muzzafar, MBBS, Donna M. Weber, M.D., Nathan Fowler, MD, Uday R Popat, MD, Sheeba K. Thomas, M.D., Michelle A. Fanale, MD, Yago Nieto, MD, PhD, Nina Shah, MD, Qaiser Bashir, MD, Fredrick B. Hagemeister, MD, Robert Z. Orlowski, M.D., Ph.D., Jatin J. Shah, M.D.
Journal: Blood
Blood (2013) 122 (21): 4310.
https://doi.org/10.1182/blood.V122.21.4310.4310
Published: 2013
Journal Articles

High-Dose Gemcitabine Combined With Busulfan and Melphalan (Gem/Bu/Mel) With Autologous Stem-Cell Transplant (ASCT) In Refractory and Relapsed Myeloma

Yago Nieto, MD, PhD, Nina Shah, MD, Uday R Popat, MD, Roy B Jones, PhD MD, Qaiser Bashir, MD, Rolland Bassett, MS, Benigno C. Valdez, PhD, Borje S Andersson, MD, PhD, Simrit Parmar, MD, Robert Z. Orlowski, M.D., Ph.D, Jatin J. Shah, M.D., Sheeba K. Thomas, M.D., Michael Wang, M.D., Richard E Champlin, MD, Muzaffar Qazilbash, M.D.
Journal: Blood
Blood (2013) 122 (21): 3346.
https://doi.org/10.1182/blood.V122.21.3346.3346
Published: 2013
Journal Articles

Role of Serum Lactate Dehydrogenase (LDH) As a Prognostic Marker for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.

Krina Patel, MD, Robert Z. Orlowski, M.D., Ph.D., Nina Shah, MD, Qaiser Bashir, Simrit Parmar, M.D., Yvonne T Dinh, Gabriela Rondon, MD, Sergio A Giralt, MD, Richard E. Champlin, Muzaffar Qazilbash, M.D.
Journal: Blood
Blood (2012) 120 (21): 3115.
https://doi.org/10.1182/blood.V120.21.3115.3115
Published: 2012
Journal Articles

High Dose Therapy Improves Survival in Systemic Light Chain Amyloidosis: 14 Year Follow up

Simrit Parmar, M.D., Joshua Howell, PharmD, Michael Wang, M.D., Mubeen A Khan, Qaiser Bashir, MD, Jatin J. Shah, M.D., Nina Shah, MD, Uday R. Popat, M.D., Sergio A Giralt, MD, Robert Z. Orlowski, M.D., Ph.D., Muzaffar Qazilbash, M.D.
Journal: Blood
Blood (2012) 120 (21): 750.
https://doi.org/10.1182/blood.V120.21.750.750
Published: 2012
Journal Articles

Feasibility of Hematopoietic Stem Cell Collection and Cryopreservation in Waldenstrom's Macroglobulinemia

Dilshad Khan, MBBS, Krina Patel, MD, Sheeba K. Thomas, MD, Donna M. Weber, M.D., Kay B Delasalle, B.S., Chitra M. Hosing, M.D., Uday R. Popat, M.D., Qaiser Bashir, MD, Nina Shah, MD, Simrit Parmar, M.D., Richard E. Champlin, Muzaffar Qazilbash, M.D.
Journal: Blood
Blood (2012) 120 (21): 4128.
https://doi.org/10.1182/blood.V120.21.4128.4128
Published: 2012
Journal Articles

Outcomes of Adults with Acute Lymphoblastic Leukemia (ALL) Following Relapse After First Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Amir Hamdi, M.D., LM Poon, M.D., Rima M. Saliba, Ph.D., Gabriela Rondon, M.D., Celina Ledesma, Muzaffar Qazilbash, M.D., Chitra M. Hosing, M.D., Roy B. Jones, MD, Ph.D., Uday R. Popat, M.D., Nieto, M.D., Ph.D., Amin M. Alousi, M.D., Stefan O. Ciurea, Elizabeth J. Shpall, M.D., Richard E. Champlin, Partow Kebriaei, M.D.
Journal: Blood
Blood (2012) 120 (21): 4215.
https://doi.org/10.1182/blood.V120.21.4215.4215
Published: 2012
Journal Articles

Sequential Treatment with Reduced Intensity Allogeneic Stem Cell Transplantation and Imatinib for Chronic Myelogenous Leukemia (CML.

Richard Champlin, M.D., Shubhra Ghosh, M.D., Gloria McCormick, R.N., Borje Andersson, M.D., Ph.D., Marcos de Lima, M.D., Paolo Anderlini, M.D., Muzaffar Qazilbash, M.D., Sergio Giralt, M.D., Jorge Cortes, M.D.
Journal: Blood
Blood (2004) 104 (11): 812.
https://doi.org/10.1182/blood.V104.11.812.812
Published: 2004